- Home
- CBT vs NXPLW Comparison
CBT vs NXPLW Comparison
Compare CBT & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBT
- NXPLW
- Stock Information
- Founded
- CBT 2019
- NXPLW N/A
- Country
- CBT United States
- NXPLW United States
- Employees
- CBT N/A
- NXPLW 166
- Industry
- CBT Major Chemicals
- NXPLW Telecommunications Equipment
- Sector
- CBT Industrials
- NXPLW Telecommunications
- Exchange
- CBT Nasdaq
- NXPLW Nasdaq
- Market Cap
- CBT N/A
- NXPLW N/A
- IPO Year
- CBT N/A
- NXPLW N/A
- Fundamental
- Price
- CBT $78.33
- NXPLW $0.15
- Analyst Decision
- CBT Hold
- NXPLW
- Analyst Count
- CBT 4
- NXPLW 0
- Target Price
- CBT $93.25
- NXPLW N/A
- AVG Volume (30 Days)
- CBT 461.7K
- NXPLW 6.4K
- Earning Date
- CBT 05-05-2025
- NXPLW 03-31-2025
- Dividend Yield
- CBT 2.19%
- NXPLW N/A
- EPS Growth
- CBT N/A
- NXPLW N/A
- EPS
- CBT 7.51
- NXPLW N/A
- Revenue
- CBT $3,991,000,000.00
- NXPLW $66,482,000.00
- Revenue This Year
- CBT $3.28
- NXPLW N/A
- Revenue Next Year
- CBT $3.56
- NXPLW N/A
- P/E Ratio
- CBT $10.43
- NXPLW N/A
- Revenue Growth
- CBT 1.71
- NXPLW 179.89
- 52 Week Low
- CBT $73.63
- NXPLW $0.25
- 52 Week High
- CBT $117.46
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- CBT 43.01
- NXPLW N/A
- Support Level
- CBT $77.35
- NXPLW N/A
- Resistance Level
- CBT $80.61
- NXPLW N/A
- Average True Range (ATR)
- CBT 3.65
- NXPLW 0.00
- MACD
- CBT -0.04
- NXPLW 0.00
- Stochastic Oscillator
- CBT 43.48
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.